A novel targeted therapy, opnimetinib (also known as DC-853), has demonstrated clinical activity in patients with advanced melanoma driven by NRAS mutations, according to data presented at the 2024 American …
Immunology
-
-
Research indicates that fractional doses of COVID-19 vaccines can elicit robust, long-lasting immune responses, offering a potential strategy for global vaccine accessibility and supply management. Studies published in journals such …
-
New Clinical Model May Reduce Unnecessary Emergency Care for Pediatric Anaphylaxis A validated prediction model can identify children with anaphylaxis who are at low risk for needing additional epinephrine after …
-
Chronic sleep deprivation and the prevalence of sleep disorders have emerged as significant public health challenges, with the Centers for Disease Control and Prevention (CDC) reporting that one in three …
-
Researchers at the Scripps Research Institute have successfully triggered the production of broadly neutralizing antibodies (bnAbs) in primates using a new HIV vaccine candidate. This preclinical advancement, detailed in the …
-
The Relationship Between Allergies and Cancer Risk: Examining the Immunological Evidence Research into the link between allergies and cancer suggests that the body’s immune response may play a dual role …
-
West Nile Virus Detected in Yakima County Mosquitoes: What Residents Need to Know Public health officials in Yakima County, Washington, have confirmed the first detection of West Nile virus (WNV) …
-
Researchers have identified a significant link between the gut bacterium Enterococcus gallinarum and the development of systemic lupus erythematosus (SLE), a chronic autoimmune disease. A study published in Science demonstrated …
-
Hyperemesis gravidarum (HG)—a severe form of pregnancy-related nausea and vomiting—is linked to a significantly higher risk of adverse maternal and fetal outcomes, including preterm birth and gestational hypertension. While standard …
-
First Patients Receive Experimental Therapy for Neuromyelitis Optica Spectrum Disorder Two patients have become the first individuals to receive an experimental autologous neural stem cell therapy, known as CNS10-NPC, as …